Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q2 2016 · 10-Q
Revenue$30.68K$30.68K−60.7% vs Q2 2015 Net Income-$653.93K-$653.93KN/M vs Q2 2015 EPS Diluted-$0.01-$0.01N/M vs Q2 2015 Gross Profit$19,961−65.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Operating Cash Flowderived-$283,141N/M Margins · derivedGross margin65.1%−9.8 pt vs Q2 2015
Operating margin-1984.2%−708.2 pt vs Q2 2015
Net margin-2131.3%+130.5 pt vs Q2 2015
ended Jun 30, 2016 · filed Aug 22, 2016 · 53 d after period end